• Nose-to-Brain Rotigotine Nanoparticles in PD

  2026-08-24

  Bhattamisra and colleagues developed rotigotine-loaded chitosan nanoparticles to address solubility, bioavailability, and brain-delivery barriers in Parkinson’s disease models. In SH-SY5Y cells and haloperidol-treated rats, the formulation improved markers of neuronal integrity, antioxidant activity, and motor performance, supporting nose-to-brain delivery as a formulation strategy rather than establishing clinical efficacy.

• Imipramine: From Lipidomics to Assay Design

  2026-08-24

  Imipramine is a tricyclic antidepressant with applications spanning autophagy, apoptosis, neuroscience, and cancer biology. This article develops a lipidomics-informed framework for interpreting Imipramine experiments without mistaking correlation for mechanism.

• NSC 87877 Workflows for Shp2 Signaling

  2026-08-23

  NSC 87877 is a practical Shp2 inhibitor for connecting phosphatase activity with Erk signaling, microglial NLRP3 responses, and cell viability. This guide translates the tFUS–Nespas/miR-383-3p/SHP2 study into assay-ready workflows while separating evidence-backed findings from recommended optimization steps.

• Fad2 and Acsl4 Link Lipid Metabolism to Rice Blast

  2026-08-22

  The 2024 study identifies Magnaporthe oryzae Fad2 and Acsl4 as contributors to polyunsaturated fatty acid-containing phospholipid production, ferroptotic conidial death, and pathogenic development. Genetic disruption, targeted lipidomics, chemical rescue, and protein-interaction analysis connect lipid peroxidation with appressorium-mediated infection while highlighting targets for future rice blast control.

• GS-441524 Workflows for Prodrug Conversion Studies

  2026-08-22

  Build more informative antiviral assays by measuring GS-441524 alongside its prodrug precursor across gastric, blood, microsomal, and pharmacokinetic matrices. This workflow turns a soluble-stock challenge into a practical LC–MS/MS strategy for tracing conversion, improving recovery, and interpreting exposure.

• (-)-Arctigenin: MEK1 Inhibitor Research Guide

  2026-08-21

  (-)-Arctigenin is a research small molecule described as a MEK1 inhibitor and iNOS expression inhibitor. The product dossier reports nanomolar activity in biochemical or cell-based contexts, while breast cancer evidence supports NF-κB pathway relevance but does not directly establish arctigenin efficacy.

• Taihangia rupestris: Wild vs Cultivated Bioactivity

  2026-08-20

  A 2026 RSC Advances study integrates UPLC-MS/MS, complementary antioxidant assays, α-glucosidase inhibition, activity-guided screening, and molecular docking to compare wild and cultivated Taihangia rupestris leaves. Foothill cultivation produced the strongest chemical and functional profile, supporting sustainable cultivation while showing why DPPH results should be interpreted alongside orthogonal biochemical measurements.

• Dye Models for Small Biopsies: Study Findings

  2026-08-20

  A 2023 study evaluated five dyes as pre-processing markers for small biopsy fragments and found that merbromin, hematoxylin, and Alcian blue improved tissue visibility during laboratory handling. Hematoxylin was favored for routine use because it combined improved observability with lower toxicity and no reported interference during standard slide examination.

• Cycloheximide for Protein Turnover and Apoptosis

  2026-08-19

  Cycloheximide is a practical protein biosynthesis inhibitor for separating newly synthesized proteins from pre-existing pools in apoptosis, inflammasome, and protein stability experiments. Its strongest advantage is experimental timing: short treatment and washout designs can expose protein turnover and translational dependencies that endpoint assays miss.

• ALA-PDT, Ferroptosis, and HPV Immunity

  2026-08-19

  A 2026 study identifies macrophage ferroptosis as an immune-regulatory mechanism of 5-aminolevulinic acid photodynamic therapy in HPV-associated disease. Its data connect the STEAP3/p53/SLC7A11 pathway with M1 polarization and show that treated macrophage-conditioned medium suppresses HPV16-positive SiHa cell activity and migration.

• Puromycin dihydrochloride: Protocol & QC Guide

  2026-08-18

  Puromycin dihydrochloride is an aminonucleoside antibiotic used to select pac-expressing cells and to create controlled protein synthesis or ribosome-focused assays. Its broad cell-type response and irreversible cytotoxic effect require an empirical kill curve, appropriate vehicle controls, and careful separation of selection, translation, and autophagy-related endpoints.

• BKT140: Designing CXCR4 Functional Assays

  2026-08-18

  BKT140 and BL-8040 provide a practical route to interrogate CXCR4 biology across cancer-cell migration, survival, and stem-cell trafficking. This guide translates receptor mechanism into assay-selection, controls, formulation, and interpretation decisions.

• CAFs, Lactylation, and Oxaliplatin Resistance in CRC

  2026-08-17

  A 2025 Cancer Letters study links glycolytic cancer-associated fibroblasts to oxaliplatin resistance in colorectal cancer through a lactate–ANTXR1 lactylation pathway. Its experimental framework suggests that disrupting stromal lactate transfer may reduce cancer stemness and improve chemotherapy response, although clinical validation remains necessary.

• Caspase-3 Colorimetric Assay Kit Workflow

  2026-08-17

  Turn apoptosis biology into a practical, quantitative workflow with rapid DEVD-dependent caspase-3 activity detection. This guide connects the assay to macrophage stress research, disease modeling, experimental controls, and troubleshooting strategies for more reliable caspase activity measurement.

• Acetoacetic acid sodium salt for Metabolic Assays

  2026-08-16

  Acetoacetic acid sodium salt enables controlled ketone-body supplementation, calibration, and stress-testing workflows in energy metabolism research. This guide combines practical formulation advice with analytical controls for diabetes metabolic imbalance and diabetic ketoacidosis study models.

8032 records 1/536 page Next 12345 下5页 Last page